跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EMERADE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
EMERADE
Authorized
STANDARD
EMERADE
bausch health, canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
84aeae21ac6f253a
Company
bausch health, canada inc.
Type
Standard
Approval Details
Approval Id
84aeae21ac6f253a
Drug Approval Canada Name
EMERADE
Product Name
EMERADE
Status
Marketed
Status Date
2020-10-08
Original Market Date
2020-10-08
Din
02458446
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular
Schedule
Ethical
Ahfs
12:12.12
Atc Original
C01CA24 EPINEPHRINE
Atc Name
c 01 ca 24
Aig Number
0104871002
Company Name
bausch health, canada inc.
Company Address
2150 Boul. St-Elzear Ouest, Laval, Quebec, Canada, H7L 4A8
Active Ingredients
EPINEPHRINE (EPINEPHRINE BITARTRATE)
0.3 MG / 0.3 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
84aeae21ac6f253a
Type
Standard
Back to Health Canada Approvals